Skip to content

H.Res. 672 · 118th Congress (2023–2025)

Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.

This resolution recognizes the challenges posed by sickle cell trait and sickle cell disease and encourages relevant screening, research, and surveillance. Sickle cell disease is a group of inherited disorders that cause abnormally shaped red blood cells.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is H.Res. 672’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Barbara Lee (D-CA-12)
Cosponsors
1 cosponsor

1 original · 0 later

  1. Rep. Danny K. Davis (D-IL-7)· Original · Sep 8, 2023
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources
  3. Expired

    Introduced → Referred to House Energy and Commerce → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Sep 8, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (1)
  1. Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.

    Display title, Official title · Introduced in House